APA (7th ed.) Citation

Ross, E. A., Tian, J., Abboud, H., Hippensteel, R., Melnick, J. Z., Pradhan, R. S., . . . Sprague, S. M. (2008). Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis. American journal of nephrology, 28(1), 97-106. https://doi.org/10.1159/000109398

Chicago Style (17th ed.) Citation

Ross, Edward A., Jin Tian, Hanna Abboud, Richard Hippensteel, Joel Z. Melnick, Rajendra S. Pradhan, Laura A. Williams, L. Lee Hamm, and Stuart M. Sprague. "Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis." American Journal of Nephrology 28, no. 1 (2008): 97-106. https://doi.org/10.1159/000109398.

MLA (9th ed.) Citation

Ross, Edward A., et al. "Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis." American Journal of Nephrology, vol. 28, no. 1, 2008, pp. 97-106, https://doi.org/10.1159/000109398.